EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Causal Effect of Low‐Density Lipoprotein Cholesterol on Chronic Kidney Disease: A Mendelian Randomization Study

Dongming Zhou iD, Kangchao Zheng, Suwei Zhang, Bingbing Zheng iD

Biochemistry Research International · 2026-01 · 2026 (1)

DOI: 10.1155/bri/3548900 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemistry Research International, online erschienen am 03.04.2026. Verfasst von Dongming Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Shantou Central Hospital, Shantou, Guangdong, China, sthospital.com. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

While dyslipidemia is associated with chronic kidney disease (CKD), conventional observational studies cannot establish causality, and previous Mendelian randomization (MR) findings on low‐density lipoprotein cholesterol (LDL‐C) and CKD remain inconsistent.

Objective

To further investigate the causal relationship between LDL‐C and CKD using MR and evaluate its independence.

Methods

We employed a two‐sample and multivariable MR (MVMR) framework. Initially, two‐sample and reverse MR analyses were performed for four lipid traits on CKD using genetic data from the IEU Open GWAS and the UK Biobank separately, with a Bonferroni‐corrected significance threshold of p < 0.0125. Subsequently, MVMR was conducted to assess the independent effect of LDL‐C after adjusting for other lipid traits ( p < 0.05). Finally, an MVMR model incorporating LDL‐C, smoking, alcohol consumption, and body mass index (BMI) was fitted to test the independence from these lifestyle confounders, followed by a sensitivity analysis with linkage disequilibrium–based confounder filtering to verify robustness.

Results

Two‐sample MR showed a significant causal effect of LDL‐C on increased CKD risk (IEU source: OR = 1.13, 95% CI: 1.03–1.23, p < 0.01; consistent results from UK Biobank), with no evidence of reverse causation. MVMR confirmed the independence of this association: LDL‐C remained significantly associated with CKD after adjusting for other lipid traits (OR = 1.21, 95% CI: 1.08–1.35, p = 0.0007) and after further adjustment for BMI, smoking, and alcohol (OR = 1.14, 95% CI: 1.04–1.25, p = 0.068). The effect direction remained consistent in the stringent sensitivity analysis.

Conclusion

LDL‐C may be an independent risk factor for CKD, the independence of which warrants further validation.

Schlagwörter

Stichwörter der Autor:innen

IEU Open GWASMendelian randomizationUK Biobankchronic kidney diseaselow-density lipoprotein cholesterol

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Shantou Central Hospital, Shantou, Guangdong, China, sthospital.com.
  • Department of Medical Ultrasonics, Shantou Central Hospital, Shantou, Guangdong, China, sthospital.com.
  • Department of Orthopedics, Shantou Central Hospital, Shantou, Guangdong, China, sthospital.com.

ORCID-Profile: Dongming Zhou, Bingbing Zheng

Zitieren

APA

Zhou, D., Zheng, K., Zhang, S., & Zheng, B. (2026). Causal Effect of Low‐Density Lipoprotein Cholesterol on Chronic Kidney Disease: A Mendelian Randomization Study. Biochemistry Research International, 2026(1). https://doi.org/10.1155/bri/3548900

Vancouver

Zhou D, Zheng K, Zhang S, Zheng B. Causal Effect of Low‐Density Lipoprotein Cholesterol on Chronic Kidney Disease: A Mendelian Randomization Study. Biochemistry Research International. 2026;2026(1). doi:10.1155/bri/3548900

BibTeX
@article{Zhou2026,
  author = {Zhou, Dongming and Zheng, Kangchao and Zhang, Suwei and Zheng, Bingbing},
  title = {Causal Effect of Low‐Density Lipoprotein Cholesterol on Chronic Kidney Disease: A Mendelian Randomization Study},
  journal = {Biochemistry Research International},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/bri/3548900}
}
Kostenlos starten →